A Single-Center, Randomized, Double-Blind, Placebo Controlled Study of the Safety, Tolerability and Pharmacokinetics of Various Concentrations of Topical SM04554 Solution in Male Subjects with Androgenetic Alopecia

Trial Profile

A Single-Center, Randomized, Double-Blind, Placebo Controlled Study of the Safety, Tolerability and Pharmacokinetics of Various Concentrations of Topical SM04554 Solution in Male Subjects with Androgenetic Alopecia

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs SM 04554 (Primary)
  • Indications Alopecia
  • Focus Adverse reactions
  • Sponsors Samumed
  • Most Recent Events

    • 08 Mar 2016 Results (n = 29) presented at the 74th Annual Meeting of the American Academy of Dermatology.
    • 23 Nov 2015 Results presented at the 9th World Congress for Hair Research (WCHR) in Miami, as per Samumed media release.
    • 18 Nov 2015 According to a Samumed media release, results from this trial will be presented at the 9th World Congress for Hair Research (WCHR).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top